Aratana builds pet drug pipeline by buying rights from Japanese company
March 02, 2018 at 15:46 PM EST
Aratana Therapeutics purchased exclusive rights to a pain treatment from Japanese drug developer AskAt Inc.
Breaking News Bar
Business News and Information
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
| ||||||
bottom clear
